SCHEMBL3787400

SCHEMBL3787400

O=C(OCCc1ccccc1[AsH]c1ccccn1)OCCc1ccccc1[AsH]c1ccccn1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP4F2 P78329 6/20 0.35
CYP4A11 Q02928 6/20 0.35
CA12 O43570 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
CA9 Q16790 1/20 0.35
LMNA P02545 2/20 0.33
TYR P14679 1/20 0.33
NPC1 O15118 2/20 0.32
RAB9A P51151 2/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
CASP3 P42574 1/20 0.32
SENP8 Q96LD8 1/20 0.32
SENP7 Q9BQF6 1/20 0.32
SENP6 Q9GZR1 1/20 0.32
SMN1; SMN2 Q16637 2/20 0.31
CES2 O00748 1/20 0.31
CES1 P23141 1/20 0.31
ALDH1A1 P00352 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2583677 0.69 MEN1 (0.51) NPC1RAB9AMEN1KMT2ASMN1; SMN2
SCHEMBL3787394 0.67 ALDH1A1 (0.33) LMNANPC1RAB9AKMT2ASMN1; SMN2
SCHEMBL1790918 0.62 ALOX5 (0.41) CYP4F2CYP4A11CA2TYRALDH1A1
SCHEMBL888133 0.62 ALDH1A1 (0.53) NPC1RAB9AMEN1KMT2ASMN1; SMN2
SCHEMBL1847344 0.62 FFAR1 (0.46) TYRNPC1RAB9AKMT2ACASP3
SCHEMBL14975361 0.62 HCAR2 (0.46) LMNANPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL983427 0.60 HCAR2 (0.61) CA1CA2CA9LMNANPC1
SCHEMBL20509994 0.60 SMN1; SMN2 (0.63) CA12CA1CA2CA9LMNA
SCHEMBL12414711 0.60 CA12 (0.56) CA12CA1CA2CA9LMNA
SCHEMBL47779 0.60 TAAR1 (0.52) NPC1RAB9AMEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2231633-A1 ANTITUMORAL COMPOUNDS Pharma Mar S.A. (ES) 2010-09-29 EP disclosed
WO-2009080761-A1 ANTITUMORAL COMPOUNDS PHARMA MAR, S.A. (ES) 2009-07-02 WO disclosed